Seronegative Neonatal Lupus: Case Report


Authors : C. Aoussar; C. Nahi; M. A Ichane; K. Mouadine; B. Chkirate

Volume/Issue : Volume 9 - 2024, Issue 10 - October


Google Scholar : https://tinyurl.com/mrxzetzk

Scribd : https://tinyurl.com/6zsnc3vb

DOI : https://doi.org/10.38124/ijisrt/IJISRT24OCT257

Note : A published paper may take 4-5 working days from the publication date to appear in PlumX Metrics, Semantic Scholar, and ResearchGate.


Abstract : Neonatal lupus erythematosus (NEL) is a rare autoimmune disease characterized by transplacental transmission of maternal antibodies, primarily directed against SSA/Ro or SSB/La proteins. Clinical manifestations include cutaneous, hematologic, hepatic, and cardiac symptoms, including congenital atrioventricular block (cAVB). Although cutaneous symptoms are often reversible and treated with topical steroids, cardiac complications, such as cAVB, are considered irreversible and can be fatal. Pregnant women with specific antibodies should be screened, and fetal echocardiography is recommended for prenatal screening. Traditional treatments include corticosteroids, although hydroxychloroquine and intravenous immunoglobulin (IVIG) may be effective alternatives to reduce the risk of cardiac complications in newborns.

References :

  1. N. Costedoat-Chalumeau et al. “Neonatal lupus”: review of the literature. The journal of internal medicine 24 (2003) 659–671
  2. Lela A. Lee. Neonatal Lupus Clinical Characteristics and Management. Pediatr Drugs 2004; 6 (2)
  3. Morel N, et al. “Neonatal lupus”: literature review. Rev Med Interne (2014),
  4. J. Blanc et al. Polymorphism and differential diagnoses of neonatal lupus erythematosus. Annals of Dermatology and Venereology (2020) 147, 258—264.
  5. Bridge RG, Foley FE (1954) Placental transmission of the lupus erythematosus factor. Am J Med Sci 227:1–8
  6. Federica Vanoni. Sebastiano AG Lava. Emilio F. Fossali. Riccardo Cavalli. Giacomo D. Simonetti. Mario G. Bianchetti. Marie-Ange Bozzini. Carlo Agostoni. Gregorio P. Milani. Neonatal Systemic Lupus Erythematosus Syndrome: a Comprehensive Review. Clinic Rev Allerg Immunol. 2017.
  7. J. Hoebeke, S. Muller. Neonatal lupus: new hypotheses concerning immunopathogenesis. Revue du Rhumatisme 72 (2005) 159–161
  8. N. Costedoat-Chalumeau et al. “Neonatal lupus”: review of the literature. The journal of internal medicine 24 (2003) 659–671
  9. Derdulska et al. Neonatal lupus erythematosus. J. Perinat. Med. 2021; 49(5): 529–538
  10. Ramphul et al. Cutaneous Neonatal Lupus Erythematosus: A Case Report 2018. Cureus 10(2): e2212.
  11. Kam Lun Hon and Alexander KC Leung. Neonatal Lupus Erythematosus. Hindawi Publishing Corporation Autoimmune Diseases Volume 2012, 6 pages
  12. E. Silverman & E. Jaeggi. Neonatal Lupus Erythematosus. 2010 Scandinavian Journal of Immunology 72, 223–225.
  13. Benay Johnson. Overview of Neonatal Lupus. Journal of Pediatric Health Care. 2013
  14. R. Cimaz, A. Duquesne. Neonatal lupus. Archives of Pediatrics 13 (2006) 473–478
  15. Jérôme Coulombe, Julie Barsalou. Neonatal lupus manifesting as a butterfly-shaped rash. CMAJ 2021.

Neonatal lupus erythematosus (NEL) is a rare autoimmune disease characterized by transplacental transmission of maternal antibodies, primarily directed against SSA/Ro or SSB/La proteins. Clinical manifestations include cutaneous, hematologic, hepatic, and cardiac symptoms, including congenital atrioventricular block (cAVB). Although cutaneous symptoms are often reversible and treated with topical steroids, cardiac complications, such as cAVB, are considered irreversible and can be fatal. Pregnant women with specific antibodies should be screened, and fetal echocardiography is recommended for prenatal screening. Traditional treatments include corticosteroids, although hydroxychloroquine and intravenous immunoglobulin (IVIG) may be effective alternatives to reduce the risk of cardiac complications in newborns.

Never miss an update from Papermashup

Get notified about the latest tutorials and downloads.

Subscribe by Email

Get alerts directly into your inbox after each post and stay updated.
Subscribe
OR

Subscribe by RSS

Add our RSS to your feedreader to get regular updates from us.
Subscribe